Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and...
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
About this item
Full title
Author / Creator
Jin, Pengfei , Guo, Xiling , Chen, Wei , Ma, Shihua , Pan, Hongxing , Dai, Lianpan , Du, Pan , Wang, Lili , Jin, Lairun , Chen, Yin , Shi, Fengjuan , Liu, Jingxian , Xu, Xiaoyu , Zhang, Yanan , Gao, George F , Chen, Cancan , Feng, Jialu , Li, Jingxin and Zhu, Fengcai
Publisher
United States: Public Library of Science
Journal title
Language
English
Formats
Publication information
Publisher
United States: Public Library of Science
Subjects
More information
Scope and Contents
Contents
Heterologous boost vaccination has been proposed as an option to elicit stronger and broader, or longer-lasting immunity. We assessed the safety and immunogenicity of heterologous immunization with a recombinant adenovirus type-5-vectored Coronavirus Disease 2019 (COVID-19) vaccine (Convidecia, hereafter referred to as CV) and a protein-subunit-bas...
Alternative Titles
Full title
Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_plos_journals_2677645487
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2677645487
Other Identifiers
ISSN
1549-1676,1549-1277
E-ISSN
1549-1676
DOI
10.1371/journal.pmed.1003953
